Results 61 to 70 of about 3,177,071 (215)

Virtual reality and psychedelics: new perspectives and new possibilities in the treatment of alcohol use disorder

Frontiers in Psychiatry
Psychedelic-assisted therapy is a remarkably promising treatment for substance use disorders and for alcohol use disorder (AUD) in particular. Research supporting psychedelics as a safe and effective pharmacotherapy for AUD and its comorbid psychiatric ...
Scott Matthews, Scott Matthews, Antonino Greco, Antonino Greco, Antonino Greco, Antonino Greco, Clara Rastelli, Clara Rastelli, Clara Rastelli, Anahita Bassir Nia, Anahita Bassir Nia, Anahita Bassir Nia   +11 more
doaj   +1 more source

Ethical and legal issues in psychedelic harm reduction and integration therapy

Harm Reduction Journal, 2021
Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of mental health problems as recent clinical trials have demonstrated strong evidence of their therapeutic benefits.
Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, Joseph Rhea, Vilmarie Fraguada Narloch   +4 more
doaj   +1 more source

Medical student attitudes and perceptions of psychedelic-assisted therapies

Frontiers in Psychiatry, 2023
IntroductionAlthough certain psychedelic agents may soon gain federal approval for use in treating specific psychiatric conditions, the utilization of such therapies in clinical practice will depend largely on the attitudes of healthcare providers. Therefore, this study assesses the current attitudes, knowledge, exposure, and acceptance of psychedelics
Irene Li, Rodney Fong, Molly Hagen, Molly Hagen, Burton Tabaac, Burton Tabaac   +5 more
openaire   +3 more sources

Pasifika Healthcare Workers' Perspectives of Psychedelic-Assisted Therapy

, 2023
Recent studies indicate that psychedelic-assisted therapy may assist with various psychological issues, including depression, anxiety, and existential distress.
Nuha, Musheerah
core  

Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the safety, tolerability and pharmacokinetics of a novel oral modified‐release psilocybin formulation (REL‐P11) in normal‐weight and overweight/obese healthy adults and to assess its suitability for controlled, subperceptual exposure, in light of emerging evidence supporting serotonergic modulation in metabolic ...
Anna Signor, Stefano Comai, Gianfranco Pasut, Franco Folli, Marco Gentilucci, Negar Gharavi, Sofia Raitsin, Thuy Van Nguyen, Marco Pappagallo, Andrea Mattarei, Paolo L. Manfredi, Sara De Martin   +11 more
wiley   +1 more source

Love and Cause: When Is Biomedically Enhanced Love Desirable?

Journal of Applied Philosophy, EarlyView.
ABSTRACT There is a philosophical debate about whether the use of biomedical enhancements to promote or sustain love in romantic relationships is compatible with the desirability of such love. We argue that enhancements are problematic in this respect only if they substantially replace the causal role of the beloved's identity in generating the lover's
Elzė Sigutė Mikalonytė, Julian Savulescu, Brian D. Earp   +2 more
wiley   +1 more source

An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.

Progress in Neuro-psychopharmacology and Biological Psychiatry
The resurgence of psychedelic-assisted psychotherapy marks a pivotal evolution in mental health treatment, challenging traditional paradigms by integrating compounds such as psilocybin, LSD, MDMA, and ketamine into clinical practice.
Kiana Askariyan, M. Joghataei, S. Dehghan, Shabnam Nohesara, Leila Rihipour, M. Mohammadi, Nooshin Ahmadirad   +6 more
semanticscholar   +1 more source

Healing together: Results from a pilot trial of 3,4‐Methylenedioxymethamphetamine‐enhanced cognitive‐behavioral conjoint therapy for posttraumatic stress disorder

Journal of Traumatic Stress, EarlyView.
Abstract Posttraumatic stress disorder (PTSD) disrupts individual well‐being and relationship health, particularly among veteran/military couples with heightened risks due to deployment, family reintegration, and traumatic stress. Although cognitive‐behavioral conjoint therapy (CBCT) and brief CBCT (bCBCT) have demonstrated strong efficacy in reducing ...
Leslie A. Morland, Chandra E. Khalifian, Dimitri Perivoliotis, Bettye Chargin, Al Alam, Tamara R. Wachsman, Dhakshin Ramanathan, Andrew W. Bismark, Christopher Stauffer, Anne C. Wagner, Abigail C. Angkaw, Kayla C. Knopp   +11 more
wiley   +1 more source

Creating Greater Safety in Psychedelic-Assisted Therapy Spaces

, 2023
As the medical legalization of psychedelic-assisted therapy quickly approaches in Western society, more stories of abuse by psychedelic therapists against clients are emerging, tracing a disturbing pattern and history of exploitation and abuses of power ...
Maira Evelyn Clancy
core  

Cancer Healthcare Workers’ Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation

, 2021
Recent clinical trials suggest that psychedelic-assisted therapy is a promising intervention for reducing anxiety and depression and ameliorating existential despair in advanced cancer patients.
William J. Evans, Suresh Muthukumaraswamy, Aideen Stack, Lisa M. Reynolds, Amelia Akroyd, Frederick Sundram   +5 more
core   +1 more source